21:20 , Dec 14, 2018 |  BC Week In Review  |  Financial News

Allen Insitute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched on Dec. 12 with...
00:23 , Dec 13, 2018 |  BC Extra  |  Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched Wednesday with $125 million...
16:44 , Apr 4, 2018 |  BC Innovations  |  Translation in Brief

Targeting TSLP

A team from the Benaroya Research Institute has demonstrated that the TSLP signaling pathway could be a new target to treat breast cancer. Thymic stromal lymphopoietin (TSLP) has shown conflicting roles in the context of...
18:16 , Apr 3, 2018 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Breast cancer Patient sample and mouse experiments suggest inhibiting TSLP signaling could help treat breast cancer. In tissue samples from breast cancer patients, levels of TSLPR in tumors were higher than in adjacent normal...
07:00 , May 12, 2011 |  BC Innovations  |  Distillery Techniques

Technology: Drug delivery

This week in techniques Approach Summary Licensing status Publication and contact information Drug delivery Matrices containing hyaluronan mimetics to increase immune function In vitro studies suggest that synthetic extracellular matrices containing hyaluronan mimetics could improve...
07:00 , Sep 11, 2008 |  BC Innovations  |  Targets & Mechanisms

Skin-deep Target

There are at least a dozen approved drugs for eczema, but none for long-term or continuous treatment of the condition. First-line drugs such as corticosteroids cannot be used for more than a few consecutive weeks...
07:00 , Sep 24, 2007 |  BC Week In Review  |  Company News

VLST management update

VLST Corp. , Seattle, Wash.   Business: Autoimmune, Inflammation   Hired: Consuelo Blosch as VP of clinical and regulatory, formerly administrative director of the clinical research program at the Benaroya Research Institute at Virginia Mason...